NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
2.200
+0.010 (0.46%)
At close: Jun 18, 2026, 4:00 PM EDT
2.247
+0.047 (2.14%)
After-hours: Jun 18, 2026, 6:45 PM EDT

NervGen Pharma Balance Sheet

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
16.5622.0717.2711.6622.4516.93
Cash & Short-Term Investments
16.5622.0717.2711.6622.4516.93
Cash Growth
14.43%27.81%48.10%-48.07%32.62%202.38%
Accounts Receivable
-0.010.1---
Other Receivables
0.090.080.420.250.030.06
Receivables
0.090.090.510.250.030.06
Prepaid Expenses
3.720.390.290.110.080.07
Other Current Assets
-0.250.940.50.590.36
Total Current Assets
20.3722.819.0112.5223.1517.42
Property, Plant & Equipment
---0.20.30
Other Intangible Assets
0.40.410.460.520.430.47
Long-Term Accounts Receivable
--0.01---
Total Assets
20.7723.2119.4913.2423.8817.9
Accounts Payable
5.880.030.033.3220.35
Accrued Expenses
-4.634.91-1.40.73
Current Portion of Leases
-0.010.10.090.09-
Other Current Liabilities
9.3515.0711.8611.736.73-
Total Current Liabilities
15.2219.7316.915.1410.221.08
Long-Term Leases
--0.010.110.2-
Total Liabilities
15.2219.7316.9115.2510.411.08
Common Stock
107.8910381.1958.9357.4142.4
Retained Earnings
-148.44-146.76-102.65-78.15-55.77-35.05
Comprehensive Income & Other
46.0947.2424.0317.2111.829.46
Shareholders' Equity
5.543.482.58-2.0113.4616.82
Total Liabilities & Equity
20.7723.2119.4913.2423.8817.9
Total Debt
-0.010.110.20.28-
Net Cash (Debt)
16.5622.0617.1611.4622.1716.93
Net Cash Growth
15.08%28.55%49.72%-48.29%30.95%202.38%
Net Cash Per Share
0.220.300.250.190.420.43
Filing Date Shares Outstanding
79.980.9370.9969.9359.1346.23
Total Common Shares Outstanding
79.979.6570.3359.6158.7846.19
Working Capital
5.153.072.11-2.6212.9316.34
Book Value Per Share
0.070.040.04-0.030.230.36
Tangible Book Value
5.153.072.11-2.5313.0316.35
Tangible Book Value Per Share
0.060.040.03-0.040.220.35